Thrombosis
News
D-dimer unreliable for ruling out pulmonary embolism in COVID-19
Clinical
Autopsy findings reveal venous thromboembolism in patients with COVID-19
What pathologic features contribute to the cause of death in COVID-19?
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
News
CVST after COVID-19 vaccine: New data confirm high mortality rate
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”
News
Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it...
News
Study gives bleeding risk estimates for VTE patients on anticoagulants
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
Clinical
Apixaban more effective, safer than rivaroxaban for Afib patients
Is apixaban more effective and safer than rivaroxaban in patients with atrial fibrillation?
News
Heparin’s COVID-19 benefit greatest in moderately ill patients
A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients...
News
DOACs best aspirin after ventricular ablation: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial and may yet be further improved....
News
Direct oral anticoagulants: Competition brought no cost relief
Medicare Part D spending since 2011 has far outpaced growth in the use of oral anticoagulants.